Pharmacovigilance Study on Eosinophilic Pneumonia Induced by Anti-MRSA Agents: Analysis Based on the FDA Adverse Event Reporting System

BACKGROUND: Eosinophilic pneumonia (EP) is a rare adverse event caused by several types of drugs, such as antibiotics; however, its characteristics remain poorly described. This study aimed to analyze the disproportionality between the occurrence of EP and anti–methicillin-resistant Staphylococcus a...

Descripción completa

Detalles Bibliográficos
Autores principales: Okada, Naoto, Niimura, Takahiro, Saisyo, Atsuyuki, Kawaguchi, Yoshitaka, Ishizawa, Keisuke, Kitahara, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438871/
https://www.ncbi.nlm.nih.gov/pubmed/37601729
http://dx.doi.org/10.1093/ofid/ofad414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438871/
https://www.ncbi.nlm.nih.gov/pubmed/37601729
http://dx.doi.org/10.1093/ofid/ofad414

Ejemplares similares